2,6-Diiodo-3,5-dimethoxypyridine

Catalog No.: 
ACBAZR018
CAS No.: 
1131335-49-3
Molecular Formula: 
C7H7I2NO2
Molecular Weight: 
390.95
2,6-Diiodo-3,5-dimethoxypyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$281.00InquiryInquiry
1g97%$840.00InquiryInquiry
5g97%$4158.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Diiodo-3,5-dimethoxypyridine
IUPAC Name2,6-diiodo-3,5-dimethoxypyridine
MDL No.MFCD11857638
Molecular FormulaC7H7I2NO2
Molecular Weight390.95
SMILESCOC1=C(I)N=C(I)C(OC)=C1
InChI KeyHEJVCFGXTPOHNW-UHFFFAOYSA-N
Synonym2,6-Diiodo-3,5-dimethoxypyridine | 1131335-49-3 | DTXSID20673836 | MFCD11857638 | AKOS015853855 | CS-0441254 | FT-0762162 | 2,6-Diiodo-3,5-dimethoxypyridine, AldrichCPR
CAS No.1131335-49-3
PubChem CID46736749

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACBAZR018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBAZR018 route product structure diagram
    ACBAZR0181131335-49-3
Inquiry

2. ACBAZR018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBAZR018 route product structure diagram
    ACBAZR0181131335-49-3
Inquiry

3. ACBAZR018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBAZR018 route product structure diagram
    ACBAZR0181131335-49-3
Inquiry

Comments (0)